1. P323: STREAMLINING PRECLINICAL IN VIVO TREATMENT TRIALS BY MULTIPLEXING GENETICALLY LABELLED PDX MODELS OF SEVERAL PATIENTS IN A SINGLE MOUSE. (23rd June 2022) Authors: Hunt, K.; Amend, D.; Ludwig, R.; Vick, B.; Wirth, A. K.; Herold, T.; Jeremias, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P402: MUTATIONS IN BONA FIDE ONCOGENES KRAS AND DNMT3A ARE NOT RELATED TO DEPENDENCY IN ESTABLISHED TUMORS, IN PDX MODELS OF ACUTE LEUKEMIA IN VIVO. (23rd June 2022) Authors: Gao, Y.; Ghalandary, M.; Becker, M.; Amend, D.; Rothenberg-Thurley, M.; Metzeler, K.; Jeremias, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P423: ADAPTING CRISPR CAS9 DROPOUT SCREENS TO IN VIVO PDX MODELS OF ACUTE LEUKEMIAS. (23rd June 2022) Authors: Ludwig, R.; Amend, D.; Bahrami, E.; Jeremias, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗